We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




The First European Lab Automation Conference Receives Rave Reviews

By LabMedica International staff writers
Posted on 08 Aug 2011
The first European scientific conference dedicated to advances in laboratory automation was given high marks by both participants and exhibitors.

The European Lab Automation (ELA) conference was held in Hamburg, Germany, from June 30 – July 1, 2011. More...
More than 1,500 scientists attended the conference, which also played host to over 150 commercial exhibitors.

The conference was divided into 10 distinct tracks, which presented the attendees with a vast amount of useful and relevant scientific content across a range of applications within the broad field of laboratory automation. The tracks included advances in biodetection and biosensors; advances in microarray technology; advances in protein crystallography; advances in separation technology; the European Agrigenomics Conference, which responded to the great interest in genetically engineered plants to optimize yields and their use in biofuels, as well as on the alteration of certain genes to increase plant resistance towards disease and infection; Lab-on-a-Chip European Congress, which was designed to review existing and new life science applications of microfluidic technologies; Next-Gen Sequencing Europe Conference; Screening Europe Conference, which dealt with high throughput and high content screening; and the World Biobanking Summit.

Ken Browne, the organizer of the event and director of Select Biosciences (Sudbury, United Kingdom) said, “We are delighted with the success of the first ELA conference and exhibition and have received some fantastic feedback from vendors and delegates alike. We are aiming to fill the need for a pan-European Automation event, and establish ELA as the forum for combining scientific content with up-to-date technology. As such, we have already booked the date for the second ELA conference and hope to continue its success.”

The next ELA conference is scheduled for Hamburg (Germany) on May 30- 31, 2012.

Related Links:
European Lab Automation (ELA) conference
Select Biosciences


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hematology Consumables
Bioblood Devices
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.